A 20-year-old male who required splenectomy following abdominal trauma was subsequently shown to have primary thrombocythaemia. This report illustrates the diagnostic problems associated with a refractory post-splenectomy thrombocytosis, and the therapeutic difficulties in the management of primary thrombocythaemia are discussed.
Introduction
Primary thrombocythaemia (PT) is a well recognized syndrome within the spectrum of myeloproliferative disorders. Typically presenting from middle-age onwards, difficulties may arise in differentiation from secondary thrombocytosis or other myeloproliferative states particularly in younger patients. This report of an unusual presentation ofPT in a 20-year-old male demonstrates some of the problems associated with the diagnosis and management of the disorder.
Case report
A 20-year-old healthy male who had worked for 4 years in a nuclear reactor plant was involved in a road traffic accident and required a laparotomy because of intra-abdominal trauma. At operation a large haemoperitoneum consequent upon a ruptured spleen was found and splenectomy was performed. The spleen was noted to be enlarged, weighing 425 109/1.
Discussion
The distinction between primary thrombocythaemia and a reactive thrombocytosis may often prove difficult. However, a platelet count in excess of 2000 x 109/1 for > 2 months after splenectomy is highly suggestive of primary thrombocythaemia (Williams, 1977) . A lesser degree of thrombocytosis (up to 1000 x 109/1) may persist for longer periods in patients where anaemia continues following splenectomy (Hirsh and Dacie, 1966) . Post-splenectomy thrombocytosis could therefore be dismissed as simply reactive, although it has been reported that splenectomy can uncover unrecognized primary thrombocythaemia (Hardisty and Wolff, 1955; Bensinger, Logue and Rundles, 1970 ).
This case clearly showed the diagnostic problem with primary thrombocythaemia, especially in very young patients. However, the degree and duration of the thrombocytosis combined with the very characteristic morphological appearances and signs of increased cell turnover are virtually diagnostic of primary thrombocythaemia. Although accurate platelet counting is difficult at such concentrations, the inhibitory effect of salicylates on platelet aggregation may have aided counting reproducibility. Unfortunately, this effect also prevented demonstration of the abnormalities of platelet function known to occur in primary thrombocythaemia (Hardisty and Wolff, 1955; McClure et al., 1966) .
Information regarding the natural history of primary thrombocythaemia is scanty, but significant morbidity and mortality from thrombosis and/or haemorrhage has been recorded, especially following splenectomy (Gunz, 1960; Silverstein, 1968) . Because of that risk, salicylate therapy was instituted in this patient. Urgent myelosuppressive therapy has been advised in patients where primary thrombocythaemia becomes apparent after splenectomy, and agents such as radioactive phosphorus and cytotoxic drugs are effective for control of primary thrombocythaemia, particularly in the elderly (Bensinger et al., 1970 (Thieffry, Buhot and Aicardi, 1975; Levinson et al., 1958; Ozer et al., 1960; Spach, Howell and Harris, 1963; Fickers and Speck, 1974 following splenectomy
